Announcements Trials
Browse Landscape

Status

Completed 6Not yet recruiting 4Withdrawn 3Unknown 2Recruiting 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 32Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Blood Specimen Collection 27Surveys and Questionnaires 24Magnetic Resonance Spectroscopy 10Observation 7Flow Cytometry 7Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6exemestane 5Radiotherapy 5Magnetic Resonance Imaging 5Immunoenzyme Techniques 5Biopsy 5Radiation 4Neoadjuvant Therapy 4Mental Status and Dementia Tests 4Genetic Testing 4Gene Expression Profiling 4Electroporation 4Data Collection 4Bevacizumab 4Trastuzumab 3Tomography, X-Ray Computed 3Tomography, Optical Coherence 3Therapeutics 3Surgical Procedures, Operative 3Sunitinib 3Sorafenib 3Registries 3Radiosurgery 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Observational × Fluorodeoxyglucose F18 × Clear all
NCT01992861 2023-06-26

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

University of Washington

Terminated
51 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡